A multicenter phase III randomized, controlled study of Theratope vaccine for metastatic breast cancer
Phase of Trial: Phase III
Latest Information Update: 25 Mar 2013
At a glance
- Drugs Cancer vaccine Theratope (Primary) ; Cyclophosphamide; Keyhole limpet haemocyanin
- Indications Advanced breast cancer
- Focus Registrational; Therapeutic Use
- 01 Aug 2011 Results published in the Oncologist.
- 10 Dec 2008 Company name changed from Biomira to Oncothyreon, and completion date added from ClinicalTrials.gov record.
- 10 Dec 2008 Status changed from active, no longer recruiting to completed.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History